AzTrials
AzTrials

PrevalenceEPPPAFNCT05777096

Prevalence of Non-traumatic Musculoskeletal Disorders in the French Paragliding Pilots Population

An observational study of Prevalence and Musculoskeletal Disorders, run by University Hospital, Grenoble at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The main objective is to determine the prevalence of non-traumatic pathologies in the paragliding population using the Nordic type questionnaire. The paragliding pilots population frequently evoque pathologies, discomfort, or pain in the course of their practice. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Prevalence, Musculoskeletal Disorders
What is being tested?
Standardised Nordic questionnaires
How many people
2,475 participants
Where
1 siteFrance
Study dates
12 Mar 2023to 4 Aug 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: 26000 people will be surveyed via the internet link. In 2021, according to the federal statistics of the FFVL accessible on the intranet of the FFVL, the number of practicing paraglider with a license was about 26000.

Who may be able to join

  • over 18 years old
  • Registered with the FFVL for the year 2022 and/or 2023
  • Paragliding in the year 2022 and/or 2023

Who cannot join

  • Adults not able to express their consent

Trial locations and contacts

1 site in 1 country.

France1 site
  • Grenoble Alpes University - Faculty of Medecine - Departement of Physiotherapy

    Saint-Martin-d'Hères, 38400

Other trials in France

About this study

The main objective is to determine the prevalence of non-traumatic pathologies in the paragliding population using the Nordic type questionnaire.

The paragliding pilots population frequently evoque pathologies, discomfort, or pain in the course of their practice. Said pain and discomfort, though unerelated any form of accident, seem to have an impact on the pilots' flying and their participation in daily life.

However, no epidemiological data are available in the literature. Investigators hypothesize the existence of non-traumatic disorders and it seems interesting to quantify the extent of the phenomenon. The results of this study might encourage the proposition of preventive measures in order to minimize a potential risk factor for paragliding accidents, and participation restrictions.

Read the detailed description

In this cross-sectional descriptive epidemiological survey, investigators wish to quantify epidemiological parameters such as the prevalence of pathologies and their consequences in the activities of daily life.

For this purpose, an email containing the link to answer the online questionnaire will be sent to all the licensees.

The link of the questionnaire will be sent directly to all clubs in each league.

The main objective is to calculate the prevalence with descriptive statistics. The primary outcome is the prevalence of non-traumatic pathology in paragliding pilots that had registered to the French Paragliding federation (FFVL) in 2022.

The prevalence will be infered from the IRSST Standardised Nordic Questionnaire with the following formula : Prevalence = (FS4+FS6=yes and FS2=no ) divided by the total number of respondents.

FS4 item "Yes" = pain in the last 12 months FS6 item "Yes" = activity limitations) FS2 item "No" = Non-traumatic disorders

This corresponds to having felt pain in the body region indicated, at least once during the last 12 months, as well as a restriction of participation following this pain, but without having suffered trauma in the area.

For the secondary outcomes will aim at exploring several hypotheses related to personal and environmental factors that could be correlated to the incidence of the nontraumatic disorders. They will be calculated with bivariate descriptive statistics using the Pvalue.io software.

Being tested
Standardised Nordic questionnaires
Keywords
paragliding, musculoskeletal Diseases, non-traumatic pathology, Standardised Nordic Questionnaire, overuse injury
Medical subject headings
Musculoskeletal Diseases, Cumulative Trauma Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Standardised Nordic questionnairesDiagnostic test

    participants will complete the SNQ online. Estimated time of participation per person: 15 minutes to fill in the questionnaires

Study groups in NCT05777096
Study groupRoleWhat they receive
registeredParagliding pilots over the age of 18. Registered at the "Fédération Française de Vol Libre" (FFVL) in the year 2022 and/or 2023 Paragliding in the year 2022 and/or 2023
Receives: Diagnostic Test: Standardised Nordic questionnaires

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Prevalence of non-traumatic pathologies in the paragliding pilot population

    The prevalence will be calculated using the IRSST's Standardised Nordic Questionnaire.

    Prevalence = (FS4+FS6=yes and FS2=no ) on total number of respondents. This prevalence will be calculated on the Population Health, with the FS4 and FS6 items. And to be more specific about atraumatic pathologies, it is necessary to have answered "no" to the FS2 item. This corresponds to having felt pain in the body region indicated, at least once during the last 12 months, as well as a restriction of participation following this pain, but without having undergone trauma in the area concerned.

    Measured: Cross sectional study. Each participant is evaluated for 15 minutes (estimated time of completion of the questionnaire)

Secondary outcomes (3)
  1. Correlations between prevalence, a body area, restriction of participation in paragliding and individual characteristics of participants

    Correlation analysis (univariate and bivariate) between responses to different questions to test for a potential association between variables

    Measured: Cross sectional study. Each participant is evaluated for 15 minutes (estimated time of completion of the questionnaire)

  2. Paragliders' beliefs about the origin of their pain.

    Number of respondents with musculoskeletal disorder (FS9=yes)/total number of positive cases ((FS4+FS6=yes and FS2=no)

    Measured: Cross sectional study. Each participant is evaluated for 15 minutes (estimated time of completion of the questionnaire)

  3. Prevalence of injuries sustained during a paragliding accident

    Number of respondents with musculoskeletal disorder due to accident/total number of pain positive cases and participation restriction ((FS4+FS6=yes and FS2.3=yes)

    Measured: Cross sectional study. Each participant is evaluated for 15 minutes (estimated time of completion of the questionnaire)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Mar 2023
  2. Study start12 Mar 2023
  3. Primary completion4 Jun 2023
  4. Study completion4 Aug 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
2,475 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05777096
Sponsor's protocol ID
2023-A00131-44
Acronym
EPPPAF
Status last verified
Mar 2024
First submitted
7 Mar 2023
Last updated
7 Mar 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Kuorinka I, Jonsson B, Kilbom A, Vinterberg H, Biering-Sorensen F, Andersson G, Jorgensen K. Standardised Nordic questionnaires for the analysis of musculoskeletal symptoms. Appl Ergon. 1987 Sep;18(3):233-7. doi: 10.1016/0003-6870(87)90010-x.

    PubMed 15676628
  • desLibris, L'enquête québécoise sur la santé de la population 2008, Canadian Electronic Library. Canada. Retrieved from https://canadacommons.ca/artifacts/1238967/lenquete-quebecoise-sur-la-sante-de-la-population-2008/1792039/ on 05 Mar 2023. CID: 20.500.12592/rvf74g.

  • Alexis Descatha, Yves Roquelaure, Agnès Aublet-Cuvelier, Catherine Ha, Annie Touranchet, et al.. Validité du questionnaire de type "Nordique" dans la surveillance des pathologies d'hypersollicitation du membre supérieur. Documents pour le Médecin du Travail, 2007, pp.509-517. ffinserm-00232629

Questions about this trial

What is this clinical trial studying?

An observational study of Prevalence and Musculoskeletal Disorders, run by University Hospital, Grenoble at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Prevalence of non-traumatic pathologies in the paragliding pilot population (time frame: Cross sectional study. Each participant is evaluated for 15 minutes (estimated time of completion of the questionnaire)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05777096, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Mar 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in